Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Windtree Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for critical conditions such as heart failure and cardiogenic shock. Its core portfolio includes the investigational drug istaroxime, targeting acute heart failure and severe heart failure-related shock, with potential applications in oncology through acquired assets. The company leverages clinical-stage research, strategic licensing, and acquisitions to commercialize therapies addressing unmet medical needs in cardiovascular and oncology markets.
This description was generated via AI from an annual report. Updated about 1 year ago.